Heart attack

March 26, 2019

Intracardiac injection of Erythropoietin/Hematopoietin protects against Myocardial infarction: Erythropoietin inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 26/March/2019, 11.39 pm

Intracardiac injection of Erythropoietin/Hematopoietin protects against Myocardial infarction: Erythropoietin inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 26/March/2019, 11.39 pm https://genomediscovery.org/wp-content/uploads/2019/03/Intracardiac.Epicardial-injection-of-Erythropoietin-protects-against-myocardial-infarction-and-cardiac-ageing-through-up-regulation-of-PNUTS.jp6g.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/03/Intracardiac.Epicardial-injection-of-Erythropoietin-protects-against-myocardial-infarction-and-cardiac-ageing-through-up-regulation-of-PNUTS.jp6g.jpg March 26, 2019 March 26, 2019

What they say: A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March 2013 issue of of the journal Nature, by Prof Dimmler,…

March 25, 2019

Molecular Hydrogen gas-based therapy for heart regeneration and repair: Intracardiac or subcutaneous injection of Hydrogen gas decreases tumor suppressor MiR-128 and cyclin-dependent kinase inhibitor p27 expression, increases SUZ12 expression, increases Cyclin E and CDK2 expression, promotes proliferation/re-entry of postnatal/adult cardiomyocytes, attenuates fibrosis, ameliorates cardiac dysfunction, and promotes heart repair in response to myocardial infarction, via up-regulation of its target gene, 25/March/2019, 2.18 pm

Molecular Hydrogen gas-based therapy for heart regeneration and repair: Intracardiac or subcutaneous injection of Hydrogen gas decreases tumor suppressor MiR-128 and cyclin-dependent kinase inhibitor p27 expression, increases SUZ12 expression, increases Cyclin E and CDK2 expression, promotes proliferation/re-entry of postnatal/adult cardiomyocytes, attenuates fibrosis, ameliorates cardiac dysfunction, and promotes heart repair in response to myocardial infarction, via up-regulation of its target gene, 25/March/2019, 2.18 pm https://genomediscovery.org/wp-content/uploads/2019/03/Intracardiac-or-subcutaneous-injection-or-inhalation-of-hydrogen-gas-increases-cardiomyocyte-proliferation.regeneration-enhances-cardiac-contractility.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/03/Intracardiac-or-subcutaneous-injection-or-inhalation-of-hydrogen-gas-increases-cardiomyocyte-proliferation.regeneration-enhances-cardiac-contractility.jpg2_.jpg March 25, 2019 March 25, 2019

Introduction: What they say: A recent study from Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA; Key Laboratory of Molecular Target and…

March 24, 2019

Ribonucleic acid-based therapy for cardiomyocyte proliferation and heart regeneration: LncRNA ROR decreases tumor suppressor MiR-128 and cyclin-dependent kinase inhibitor p27 expression, increases SUZ12 expression, increases Cyclin E and CDK2 expression, promotes proliferation/re-entry of postnatal/adult cardiomyocytes, attenuates fibrosis, ameliorates cardiac dysfunction, and promotes heart repair in response to myocardial infarction, via up-regulation of its target gene, 24/March/2019, 5.22 pm

Ribonucleic acid-based therapy for cardiomyocyte proliferation and heart regeneration: LncRNA ROR decreases tumor suppressor MiR-128 and cyclin-dependent kinase inhibitor p27 expression, increases SUZ12 expression, increases Cyclin E and CDK2 expression, promotes proliferation/re-entry of postnatal/adult cardiomyocytes, attenuates fibrosis, ameliorates cardiac dysfunction, and promotes heart repair in response to myocardial infarction, via up-regulation of its target gene, 24/March/2019, 5.22 pm https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-ROR-increases-cardiomyocyte-proliferation.regeneration-enhances-cardiac-contractility-and-attenuates-pathogenesis-associated-with-myocardial-infarction.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-ROR-increases-cardiomyocyte-proliferation.regeneration-enhances-cardiac-contractility-and-attenuates-pathogenesis-associated-with-myocardial-infarction.jpg2_.jpg March 24, 2019 March 24, 2019

March 22, 2019

A gaseous way to keep cardiac diseases at bay: Hydrogen gas-based cardiac rejuvenation therapy: Inhalation or Subcutaneous injection of hydrogen gas suppresses tumor suppressor INK4a/p16 expression, and inhibits dilated cardiomyopathy, via up regulation of its target gene, 22/March/2019, 8.40 am

A gaseous way to keep cardiac diseases at bay: Hydrogen gas-based cardiac rejuvenation therapy: Inhalation or Subcutaneous injection of hydrogen gas suppresses tumor suppressor INK4a/p16 expression, and inhibits dilated cardiomyopathy, via up regulation of its target gene, 22/March/2019, 8.40 am https://genomediscovery.org/wp-content/uploads/2019/03/2-Hydrogen-gas-promotes-cardiomyocyte-dedifferentiation-and-proliferation-inhibits-cardiac-senescence-cardiomyopathy-diabetic-nephropathy-insulin-resistance-and-promotes-longevity1-1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/03/2-Hydrogen-gas-promotes-cardiomyocyte-dedifferentiation-and-proliferation-inhibits-cardiac-senescence-cardiomyopathy-diabetic-nephropathy-insulin-resistance-and-promotes-longevity1-1.jpg March 22, 2019 March 22, 2019

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: A gaseous way to keep cardiac diseases at bay: Hydrogen gas-based cardiac rejuvenation therapy: Inhalation or Subcutaneous…

March 21, 2019

Hydrogen gas-based therapy for attenuating pathogenesis-associated with Myocardial infarction: Subcutaneous injection or inhalation of hydrogen gas decreases IRF3, GM-CSF (Granulocyte-macrophage colony-stimulating factor) and GRK2(G protein-coupled receptor kinase) expression, inhibits undue leukocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits ventricular dilation, and promotes heart repair and survival, via up regulation of its target gene, 21/March/2019, 7.45 pm

Hydrogen gas-based therapy for attenuating pathogenesis-associated with Myocardial infarction: Subcutaneous injection or inhalation of hydrogen gas decreases IRF3, GM-CSF (Granulocyte-macrophage colony-stimulating factor) and GRK2(G protein-coupled receptor kinase) expression, inhibits undue leukocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits ventricular dilation, and promotes heart repair and survival, via up regulation of its target gene, 21/March/2019, 7.45 pm https://genomediscovery.org/wp-content/uploads/2019/03/2-Hydrogen-gas-H2-enhances-cardiac-contractility-and-attenuates-pathogenesis-associated-with-myocardial-infarction-through-down-regulation-of-IRF3-GRK2-and-GMCSF-and-other-inflammatory-mediators-1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/03/2-Hydrogen-gas-H2-enhances-cardiac-contractility-and-attenuates-pathogenesis-associated-with-myocardial-infarction-through-down-regulation-of-IRF3-GRK2-and-GMCSF-and-other-inflammatory-mediators-1.jpg March 21, 2019 March 21, 2019

Introduction: What they say: A recent study from Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA; and Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston,…

March 20, 2019

Hydrogen gas-based regenerative stem cell therapy for Myocardial Infarction: Subcutaneous injection of hydrogen gas inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of its target gene, 21/March/2019, 12.06 am

Hydrogen gas-based regenerative stem cell therapy for Myocardial Infarction: Subcutaneous injection of hydrogen gas inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of its target gene, 21/March/2019, 12.06 am https://genomediscovery.org/wp-content/uploads/2019/03/Subcutaneous-injection-of-hydrogen-gas-protects-against-myocardial-infarction-and-cardiac-ageing-through-up-regulation-of-PNUTS.jpg3_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/03/Subcutaneous-injection-of-hydrogen-gas-protects-against-myocardial-infarction-and-cardiac-ageing-through-up-regulation-of-PNUTS.jpg3_.jpg March 20, 2019 March 20, 2019

A gaseous way to keep cardiac diseases at bay: Hydrogen gas-based cardiac rejuvenation therapy: Inhalation or Subcutaneous injection of hydrogen gas suppresses tumor suppressor INK4a/p16 expression, and inhibits dilated cardiomyopathy, via up regulation of its target gene, 22/March/2019, 8.40 am

Popular Post